ATE221784T1 - Arzneimittel zur heilung von thrombozytopenie - Google Patents

Arzneimittel zur heilung von thrombozytopenie

Info

Publication number
ATE221784T1
ATE221784T1 AT96907755T AT96907755T ATE221784T1 AT E221784 T1 ATE221784 T1 AT E221784T1 AT 96907755 T AT96907755 T AT 96907755T AT 96907755 T AT96907755 T AT 96907755T AT E221784 T1 ATE221784 T1 AT E221784T1
Authority
AT
Austria
Prior art keywords
thrombocytopenia
cure
medicine
thrombocyte
thrombocytes
Prior art date
Application number
AT96907755T
Other languages
English (en)
Inventor
Yasushi Shimonaka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE221784T1 publication Critical patent/ATE221784T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96907755T 1995-04-02 1996-04-02 Arzneimittel zur heilung von thrombozytopenie ATE221784T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11221895 1995-04-02
PCT/JP1996/000898 WO1996031230A1 (fr) 1995-04-02 1996-04-02 Composition medicinale pour guerir la thrombopenie

Publications (1)

Publication Number Publication Date
ATE221784T1 true ATE221784T1 (de) 2002-08-15

Family

ID=14581220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96907755T ATE221784T1 (de) 1995-04-02 1996-04-02 Arzneimittel zur heilung von thrombozytopenie

Country Status (7)

Country Link
US (1) US6258352B1 (de)
EP (1) EP0823257B1 (de)
AT (1) ATE221784T1 (de)
AU (1) AU700250B2 (de)
CA (1) CA2217122C (de)
DE (1) DE69622854T2 (de)
WO (1) WO1996031230A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258352B1 (en) 1995-04-02 2001-07-10 Chugai Seiyaku Kabushiki Kaisha Compositions and methods of treating thrombocytopenia with IL-15
AU732306B2 (en) * 1997-10-14 2001-04-12 Chugai Seiyaku Kabushiki Kaisha Potentiator for antibody against lymphoid tumor
EP1213028B1 (de) * 1999-08-23 2008-08-13 Chugai Seiyaku Kabushiki Kaisha Verstärker der hm1.24 antigen-expression
EP1364657B1 (de) * 2001-02-07 2016-12-28 Chugai Seiyaku Kabushiki Kaisha Mittel gegen myelozytenleukämie
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
HU229776B1 (hu) * 2001-08-23 2014-07-28 Genmab As Interleukin 15-re (IL-15-re) specifikus emberi antitestek
US20070110714A1 (en) * 2003-09-08 2007-05-17 Norio Hayashi Medicinal composition for treatment of chronic hepatitis c
CA2954741C (en) 2013-10-13 2023-10-03 Nova Southeastern University Identification of a natural killer cell population as potential therapeutic targets for gulf war illness and myalgic encephalomyelitis/chronic fatigue syndrome
CN104212808B (zh) * 2014-09-05 2017-03-08 中国科学院广州生物医药与健康研究院 重组人白介素15长肽段及其生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747024A (en) * 1993-03-08 1998-05-05 Immunex Corporation Vaccine adjuvant comprising interleukin-15
US5552303A (en) * 1993-03-08 1996-09-03 Immunex Corporation DNA encoding epithelium-derived T-cell factor
CA2186747C (en) * 1994-04-06 2009-01-27 Kenneth H. Grabstein Interleukin-15
US6258352B1 (en) 1995-04-02 2001-07-10 Chugai Seiyaku Kabushiki Kaisha Compositions and methods of treating thrombocytopenia with IL-15

Also Published As

Publication number Publication date
CA2217122C (en) 2004-10-26
EP0823257A1 (de) 1998-02-11
EP0823257A4 (de) 1998-04-01
DE69622854D1 (de) 2002-09-12
AU700250B2 (en) 1998-12-24
DE69622854T2 (de) 2003-04-10
EP0823257B1 (de) 2002-08-07
CA2217122A1 (en) 1996-10-10
US6258352B1 (en) 2001-07-10
AU5123696A (en) 1996-10-23
WO1996031230A1 (fr) 1996-10-10

Similar Documents

Publication Publication Date Title
FR2698875B1 (fr) Système silicone modulateur d'adhérence et son utilisation pour la préparation de compositions antiadhérentes durcissables.
ATE207080T1 (de) Multivalente antigen-bindende proteine
ATE221784T1 (de) Arzneimittel zur heilung von thrombozytopenie
ID30373A (id) PARAHERKUAMIDA ANTIPARASIT (Pecahan P-962086)
DE69633194D1 (de) Kombination pdgf, kgf, igf und igfbp zur wundheilung
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
ATE161737T1 (de) Biokeramisches system zur abgabe von bioaktiven stoffen
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
DK0625354T3 (da) Lægemiddel indeholdende underenhed p40 af interleukin-12
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
IS4967A (is) Bindill tengdur æxlisdrepthætti
DE69808620D1 (de) Universell verwendbares bluttplasma
ATE181237T1 (de) Substituierte cyclohexan-derivate zur behandlung von krankheiten
DE69943308D1 (de) Hohlraum-induzierte allosterische Modifikation von intermolekularen Interaktionen und Verfahren zur Identifikation von Verbindungen, die diese bewirken
IT1240336B (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DE69626522D1 (de) Peptide mit pronociceptiveigenschaften
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
FI972929A0 (fi) Kollageeniin perustuvia menetelmiä ja koostumuksia immuunijärjestelmän välittämien sairauksien hoitamiseksi
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
ZA966953B (en) Pharmaceutical composition.
DK0655251T3 (da) Farmaceutisk præparat til forebyggelse eller behandling af knoglebrud
AU1506692A (en) Pharmaceutical compositions
ATE142998T1 (de) Schabenbekämpfungsverfahren und mittel zur bekämpfung von schaben
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties